Destroying senescent cells by suicide gene-meditated ablation of p16Ink4a-expressing cells or using senolytic drugs improved steatosis in two NASH models [18,22]. This evidence concerns the gene CDKN2A and metabolic dysfunction-associated steatohepatitis.